BioCentury
ARTICLE | Distillery Therapeutics

RNA editing of MECP2 for Rett syndrome

October 4, 2022 11:48 PM UTC

RNA editing to restore normal expression of the mutated transcription factor MECP2 could help treat Rett syndrome. The RNA editor consisted of an AAV expressing an engineered hyperactive catalytic ADA...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article